Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Int J Tuberc Lung Dis ; 25(11): 911-916, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34686233

ABSTRACT

BACKGROUND: Recommended by the World Health Organization as an initial diagnostic test for TB in children, Xpert® MTB/RIF is widely implemented in many countries, including Kenya.METHODS: Three hundred HIV-positive and negative children (<5 years) were enrolled in Kisumu County, Kenya, from October 2013 to August 2015. Multiple specimen types were collected from each child and tested using Xpert, liquid culture, and phenotypic drug susceptibility testing (DST). Samples positive for rifampin (RIF) resistance on Xpert were tested using line-probe assay and sequencing.RESULTS: Of 32 children with bacteriologically confirmed TB, 27 had positive Xpert results. Of these, 3/27 (11%, 95% CI 4-28) had RIF resistance detected on Xpert, but not by phenotypic DST, line-probe assay, or sequencing. For these three children, five Xpert tests showed RIF resistance; all five tests had semi-quantitative "very low" results and delay or absence of probe D signal, whereas no Xpert results with higher semi-quantitative results showed RIF resistance. All three children responded well to standard TB treatment.CONCLUSIONS: False RIF resistance may be detected in pediatric specimens. Further study is needed to determine if false RIF resistance is associated with low bacterial load.


Subject(s)
Antibiotics, Antitubercular , Mycobacterium tuberculosis , Tuberculosis, Pulmonary , Antibiotics, Antitubercular/therapeutic use , Child , Drug Resistance, Bacterial , Humans , Microbial Sensitivity Tests , Mycobacterium tuberculosis/genetics , Rifampin/pharmacology , Sensitivity and Specificity , Tuberculosis, Pulmonary/drug therapy
3.
Int J Tuberc Lung Dis ; 22(12): 1443-1449, 2018 12 01.
Article in English | MEDLINE | ID: mdl-30606316

ABSTRACT

SETTING: The household contacts (HHCs) of multidrug-resistant tuberculosis (MDR-TB) index cases are at high risk of tuberculous infection and disease progression, particularly if infected with the human immunodeficiency virus (HIV). HIV testing is important for risk assessment and clinical management. METHODS: This was a cross-sectional, multi-country study of adult MDR-TB index cases and HHCs. All adult and child HHCs were offered HIV testing if never tested or if HIV-negative >1 year previously when last tested. We measured HIV testing uptake and used logistic regression to evaluate predictors. RESULTS: A total of 1007 HHCs of 284 index cases were enrolled in eight countries. HIV status was known at enrolment for 226 (22%) HHCs; 39 (4%) were HIV-positive. HIV testing was offered to 769 (98%) of the 781 remaining HHCs; 544 (71%) agreed to testing. Of 535 who were actually tested, 26 (5%) were HIV-infected. HIV testing uptake varied by site (median 86%, range 0-100%; P < 0.0001), and was lower in children aged <18 years than in adults (59% vs. 78%; adjusted for site P < 0.0001). CONCLUSIONS: HIV testing of HHCs of MDR-TB index cases is feasible and high-yield, with 5% testing positive. Reasons for low test uptake among children and at specific sites-including sites with high HIV prevalence-require further study to ensure all persons at risk for HIV are aware of their status.


Subject(s)
HIV Infections/diagnosis , Mass Screening/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Tuberculosis, Multidrug-Resistant/complications , Adolescent , Adult , Child , Cross-Sectional Studies , Developing Countries , Family Characteristics , Female , HIV Infections/complications , HIV Infections/epidemiology , Humans , Internationality , Logistic Models , Male , Middle Aged , Prevalence , Risk Factors , Severity of Illness Index , Tuberculosis, Multidrug-Resistant/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL